Poster Abstract Session:
236. Diagnostics - Mycology
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Utilization of the T2 Candida Panel for rapid Candida species detection in a large community hospital
Ali Hassoun, MD FIDSA FACP; Mohammed Abdulhaleem, MD; Jonathan Edwards, PharmD, BCPS AQ-ID
  • T2_Poster_Final (1).pdf (1.2 MB)
  • Relationship of T2Candida Panel to Disease Severity, Mortality and Time to Therapy in Patients with Candidemia
    Orlando D Turner, MD; Justin F Hayes, MD; Todd P McCarty, MD; Malia Manning, RPH; Craig J Hoesley, MD; Peter G Pappas, MD
  • T2MR poster_Final.pdf (92.4 kB)
  • High-volume sputum culture for the diagnosis of pulmonary aspergillosis
    Pascalis Vergidis, MD, MSc; Caroline Moore, PhD; Riina Rautemaa-Richardson, PhD, FRCPath; Malcolm Richardson, PhD, FRCPath
    Automated Detection of Candida auris Direct from Whole Blood by T2MR
    Brendan Manning, Ph.D.; Jessica. L Snyder, Ph. D.; Benjamin Chang, BSc; Cathy Wong, BSc; Trissha Higa, BSc; Robert Shivers, Ph. D.; Thomas. J Lowery, Ph. D.
    Contribution of the qPCR for the diagnosis of pneumocystosis
    Nahema Issa, MD; Frederic Gabriel, MD; Gildas Baulier, resident; Isabelle Accoceberry, MDPhD; Gaelle Mourissoux, MD; Olivier Guisset, MD; Fabrice Camou, MD
  • POSTER PCP IDWEEK 2017b.pdf (507.4 kB)
  • Endocarditis Is Not Rare and Is An Independent Predictor of Mortality in Candidaemia
    Chaw Aye, MBBS; Alex Choo, MBBS; Robert Horvath, MBBS, FRACP, FRACPA
    Comparison of one versus two BACTEC Myco/F Lytic bottles for recovery of fungi and mycobacteria.
    Poornima Ramanan, MD; Cathy Schleck, BSEE; William Harmsen, MS; Emily Vetter, BS; Nancy L. Wengenack, PhD, FIDSA
  • Myco-F lytic IDweek 2017.pdf (517.4 kB)
  • Utility of Serial β-D-Glucan Levels in Patients with High Risk for Invasive Candidiasis – A Potential Tool for Antifungal Stewardship
    Alvin Qijia Chua, BSc (Pharm) (Hons); Sarah Si Lin Tang, BSc (Pharm) (Hons); Shin Yi Ng, MBBS, FCCP; Winnie Lee, BPharm (Hons), MSc (Epi); Eleanor Jing Yi Cheong, BSc (Pharm)(Hons); Liwen Loo, BSc (Pharm) (Hons); Yvonne Peijun Zhou, BSc (Pharm) (Hons); Nathalie Grace Sy Chua, BSc (Pharm) (Hons); Cheryl Li Ling Lim, Msc Infectious Diseases; Maciej Piotr Chlebicki, MBBS, ABIM; Ban Hock Tan, MBBS, FRCP (UK); Andrea L. Kwa, PharmD
  • IDWeek poster (BDG).pdf (2.9 MB)
  • Frequent False Positive Bronchoalveolar Lavage Galactomannan Values in a Real World Setting
    Audrey Le, MD; Nour Ismail, MD; David Kubiak, PharmD; Dimitrios Farmakiotis, MD, FACP; Sophia Koo, MD, FIDSA
    First nine cases of Candida auris infection Reported in Central America: Importance of acurate diagnosis and susceptibility testing
    Ana Belen Arauz Rodriguez, MD; Diego H. Caceres, MSc; Erika Santiago, Microbiologist; Paige Armstrong, MD MHS; Amalia Rodriguez French, MD; Susan Arosemena, MD; Carolina Ramos, RN; Andres Espinosa-Bode, MD; Jovanna Borace, Microbiologist; Lizbeth Hayer, MD; Israel Cedeño, MD; Nestor Sosa, MD; Elizabeth L. Berkow, PhD; Shawn R Lockhart, PhD; Brendan R. Jackson, MD, MPH; Tom Chiller, MD, MPH
  • Candida auris.pdf (2.3 MB)
  • Experience with β-D-Glucan Assay for Diagnosis of Invasive Candidiasis in ICU Patients: Pilot Study from India
    Nitin Bansal, MD; Ram Gopalakrishnan, MD, MRCP, AB (Internal Medicine), AB (Infectious Diseases), FIDSA; Nandini Sethuraman, MD
  • BDG poster.pdf (127.7 kB)
  • Clinical Utility of Broad-Range Fungal PCR
    Ryan Bemke, M.D.; Derrick Chen, MD
    PCR-based Diagnosis of Mucormycosis Targeting Mucorales specific Genes
    Clara Baldin, PhD; Sameh Soliman, PhD; Heewon Jeon, BS; Teclegiorgis Gebremariam, MS; Sondus Alkhazraji, PhD; Vincent Bruno, PhD; John Edwards, MD; Ashraf Ibrahim, PhD
    Does a Negative Rapid Diagnostic Test for Detection of Candida Bloodstream Infection Lead to Less Antifungal Use?
    Tanaya Bhowmick, MD; Rashi Sharma, MD; Melvin Weinstein, MD; Navaneeth Narayanan, Pharm D, BCPS; Thomas Kirn, MD, PhD
  • T2 Poster IDweek 2017.pdf (603.0 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.